Prevalence and treatment strategies of dyskinesia in patients with Parkinson’s disease Short communication First Online: 10 April 2007 Received: 13 February 2007 Accepted: 07 March 2007 DOI:
Cite this article as: Müller, T., Woitalla, D., Russ, H. et al. J Neural Transm (2007) 114: 1023. doi:10.1007/s00702-007-0718-4 Summary
A study into the prevalence and treatment of dyskinesia in Parkinson’s disease (PD) patients was performed with 380 PD specialists-completed interviews relating to PD and retrospectively completed 1900 patient record forms for patients with dyskinesia. Physicians reported, that 34% of their PD patients experience dyskinesia, 57% of dyskinetic PD patients were affected by moderately-to-completely disabling dyskinesia. Treatment of dyskinesia was looked upon as not satisfactory, fractionating of levodopa dose was used as first choice therapeutic option of dyskinesia.
Keywords: Parkinson’s disease, dyskinesia, levodopa, patient disability, physician satisfaction References Ahlskog, JE, Muenter, MD 2001 Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature Mov Disord 16 448 458 CrossRef PubMed Google Scholar Chapuis, S, Ouchchane, L, Metz, O, Gerbaud, L, Durif, F 2005 Impact of the motor complications of Parkinson’s disease on the quality of life Mov Disord 20 224 230 CrossRef PubMed Google Scholar Fahn, S, Oakes, D, Shoulson, I, Kieburtz, K, Rudolph, A, Lang, A, Olanow, CW, Tanner, C, Marek, K 2004 Levodopa and the progression of Parkinson’s disease N Engl J Med 351 2498 2508 CrossRef PubMed Google Scholar Olanow, CW, Watts, RL, Koller, WC 2001 An algorithm (decision tree) for the management of Parkinson’s disease (2001): treatment guidelines Neurology 56 S1 S88 PubMed Google Scholar Pahwa, R, Factor, SA, Lyons, KE, Ondo, WG, Gronseth, G, Bronte-Stewart, H, Hallett, M, Miyasaki, J, Stevens, J, Weiner, WJ 2006 Practice parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 66 983 995 CrossRef PubMed Google Scholar Rascol, O, Brooks, DJ, Korczyn, AD, De Deyn, PP, Clarke, CE, Lang, AE, Abdalla, M 2006 Development of dyskinesias in a 5-year trial of ropinirole and L-dopa Mov Disord 21 1844 1850 CrossRef PubMed Google Scholar Schrag, A, Quinn, N 2000 Dyskinesias and motor fluctuations in Parkinson’s disease. A community-based study Brain 123 2297 2305 CrossRef PubMed Google Scholar Silva-Junior, FP, Braga-Neto, P, Sueli, MF, de Bruin, VM 2005 Amantadine reduces the duration of levodopa-induced dyskinesia: a randomized, double-blind, placebo-controlled study Parkinsonism Relat D 11 449 452 CrossRef Google Scholar